- Report
- April 2025
- 164 Pages
Global
From €4972EUR$5,450USD£4,276GBP
- Report
- March 2025
- 175 Pages
Global
From €4096EUR$4,490USD£3,523GBP
- Report
- July 2024
- 142 Pages
Global
From €2736EUR$2,999USD£2,353GBP
- Report
- July 2024
- 164 Pages
Global
From €2281EUR$2,500USD£1,961GBP
- Report
- July 2024
- 121 Pages
North America
From €2736EUR$2,999USD£2,353GBP
- Report
- July 2024
- 162 Pages
Africa
From €2281EUR$2,500USD£1,961GBP
- Report
- July 2024
- 288 Pages
Global
From €5235EUR$5,939USD£4,350GBP
- Report
- February 2025
- 274 Pages
Global
From €4516EUR$4,950USD£3,884GBP
- Report
- October 2024
- 190 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 192 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 192 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 192 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- October 2024
- 195 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- November 2024
- 120 Pages
Global
From €5428EUR$5,950USD£4,668GBP
- Report
- October 2024
- 198 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- May 2024
- 134 Pages
Global
From €5929EUR$6,499USD£5,099GBP
- Report
- June 2024
- 200 Pages
Global
From €7253EUR$7,950USD£6,237GBP
- Report
- February 2025
- 185 Pages
Global
From €4105EUR$4,500USD£3,531GBP
- Report
- December 2024
- 59 Pages
Global
From €3645EUR$3,995USD£3,134GBP
- Report
- December 2024
Global
From €6842EUR$7,500USD£5,884GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more